People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding Co Ltd. | — | Pharmaceuticals | Series C | $40.0M | $1.4B | 2016 |
Jim Engelhart at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jim Engelhart on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Declan Doogan | 1 | 6 |
| Greg Bailey | 1 | 5 |
| John Childs | 1 | 3 |
| Vladimir Coric, M.D. | 1 | 1 |
| Kimberly Gentile | 1 | 1 |
| Kam Shah | 1 | 1 |
| John Tilton | 1 | 1 |
| Robert Berman, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.